M. Lovegren

Topotecan and liposomal doxorubicin in recurrent ovarian cancer: is sequence important?

E. Venkatraman, P. Sabbatini, J. Dupont, 2005, International Journal of Gynecologic Cancer.

A Pharmacokinetic Bioequivalence Study Comparing Sublingual Riluzole (BHV‐0223) and Oral Tablet Formulation of Riluzole in Healthy Volunteers

R. Berman, R. Larouche, V. Coric, 2020, Clinical pharmacology in drug development.

Safety of Rimegepant, an Oral CGRP Receptor Antagonist, Plus CGRP Monoclonal Antibodies for Migraine

R. Lipton, V. Coric, D. Kudrow, 2020, Headache.

Efficacy of entecavir with or without tenofovir disoproxil fumarate for nucleos(t)ide-naïve patients with chronic hepatitis B.

Huy Trinh, A. Lok, U. Akarca, 2012, Gastroenterology.

Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial.

E. Venkatraman, R. Barakat, R. Maki, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Safety, tolerability, and efficacy of zavegepant 10 mg nasal spray for the acute treatment of migraine in the USA: a phase 3, double-blind, randomised, placebo-controlled multicentre trial

P. Goadsby, V. Coric, Jennifer Madonia, 2023, The Lancet Neurology.

Potential for treatment benefit of small molecule CGRP receptor antagonist plus monoclonal antibody in migraine therapy

R. Lipton, V. Coric, D. Kudrow, 2020, Neurology.